Connect with us
Rovi announced that it estimates its operating income will decrease by around 10% compared to 2023. This forecast has been justified, mainly, by the fact that...
PharmaMar is a biopharmaceutical company based in Madrid, specializing in the discovery, development, and commercialization of new antitumor drugs of marine origin. The company has a...
This week the Catalan pharmaceutical company announced an annual growth of 22% in its income until the third quarter of 2023, which amounted to €237 million....
As hot no-code AI tools hit the market, non-technical entrepreneurs and businesses are spinning up AI apps faster than you can say ChatGPT. Leading the market...
As part of the transaction, Galapagos will also transfer to Alfasigma the European and U.K. marketing authorizations and related commercial, medical, and development activities, as well...
Novartis has acquired global rights to develop, manufacture, and commercialize Leqvio under a licensing and collaboration agreement with Alnylam Pharmaceuticals, which is a leader in RNA...
The agreement between the two companies allows Debiopharm to access licensing options to continue the development of SunRock Biopharma's antibodies, integrating Debiopharm's innovative conjugation technologies, called...
The Viennese biotech company has developed a type of vaccine based on genetically modified arenaviruses. In the case of HB-200, these are vectors based on the...
The agreement signed between Microsoft and Ribera also involves collaboration with Futurs, the technological subsidiary of the Ribera Group, which thus becomes a partner of the...
The way stablecoins work is quite simple: for every stablecoin issued, the issuing company holds a corresponding equivalent value in secured assets. This means that if...